Skip to main content

Table 1 Clinical characteristics of the study patients with PHSC and PHS

From: Clinical and imaging characteristics of primary hepatic sarcomatoid carcinoma and sarcoma: a comparative study

Variable PHSC (n = 23) PHS (n = 16) P value
Age (y)a 54.0 ± 9.9 54.4 ± 13.4 0.276
Male: female ratio 20:3 11:5 0.235
Liver hepatitis cirrhosis 14 (73.7) 10 (62.5) 0.716
Clinical manifestations 11 (52.4) 11 (73.3) 0.500
Tumor markers
 AFP 9 (47.4) 5 (33.0) 0.495
 Ca19–9 5 (35.7) 2 (14.3) 0.385
 CEA 1 (6.7) 0 0.999
 Vascular invasion 13 (56.5) 4 (25.0) 0.099
 Intrahepatic metastasis 9 (40.9) 4 (25.0) 0.490
 Extrahepatic metastasis 12 (57.1) 6 (37.5) 0.325
  1. Note. Unless otherwise specified, data are numbers of patients, with percentages in parentheses, AFP A-fetoprotein, CA 19–9 Carbohydrate antigen 19–9, CEA Carcinoembryonic antigen
  2. aData are medians, with ranges in parentheses